Business · 04/11/20261 min read

Avaada Electro achieves major milestone with 7.1 GW of ALMM-listed TOPCon Solar Cell Manufacturing Capacity

Summary

The latest notification of MNRE recognises 7,117 MW N-type TOPCon solar cell manufacturing capacity at Avaada Electro's Butibori facility in Maharashtra Advanced G12 TOPCon technology with manufacturer-declared cell...

Original source language: PR Newswire UK — News ReleasesOpen original release →

Related companies

WITH
Open profile →Explore businesses on Business Maps →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Renewable Energy News Business Technology News Global Markets News Trade Regulation News Fintech for Business: Payments & Banking News Supply Chain News

Related business signals

Business · 11/4/2026

Nearly 1.5 million registered UK users on GoWish as wishlist app exceeds 20 million worldwide

COPENHAGEN, Denmark, November 4, 2026 — The Danish-based wishlist app and social shopping platform GoWish has officially surpassed 20 million registered users worldwide, marking a major milestone in its...

Read summary →

Business · 11/4/2026

CVS Health to separate pharmacy chain from health insurance

CVS Pharmacy will be separate from CVS Health, housing major insurer Aetna and benefits manager Caremark CVS Health , the largest US healthcare conglomerate valued at $117 billion, has announced its plans to split off its...

Read summary →

Business · 11/4/2026

Opinion/decision on a PIP: Uplizna, inebilizumab, type of decision: PM: decision on the application for modification of an agreed PIP, area of treatment: Musculoskeletal and connective tissue disorders, number of PIP: EMA/PE/0000252649

Opinion/decision on a PIP: Uplizna, inebilizumab, type of decision: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective...

Read summary →

Business · 11/4/2026

Opinion/decision on a plan of investigation for children (PIP): Joenja, leniolisib phosphate, type of decision: PM: Decision on the application for modification of an agreed PIP, therapeutic area: Immunology-Rheumatology-Transplantation, number of PIP: EMA/PE/0000248263

Opinion/decision on a PIP: Joenja, leniolisib phosphate, type of decision: PM: Decision on the application for modification of an agreed PIP, therapeutic area:...

Read summary →

Business · 11/4/2026

Opinion/decision on a plan of investigation for paediatric use (PIP): Zebinix, eslicarbazepine acetate, type of decision: PM: Decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders;Neurology, PIP number: EMA/PE/0000248063

Opinion/decision on a plan of investigation for paediatrics (PIP): Zebinix, eslicarbazepine acetate, type of decision: PM: decision on the application for modification of an agreed PIP, therapeutic area: nervous system...

Read summary →

Business · 11/4/2026

Milestone for contactless fingerprint biometrics: DERMALOG qualifies for the prestigious NIST FastCAP program

The successful NIST FastCAP qualification of DERMALOG marks an important advance in contactless fingerprint biometrics, enabling fast and reliable identification for mobile and digital applications.

Read summary →